US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 20 | 14 | 25 | 23 | 24 |
| Cost of Goods | 5 | 5 | 6 | 7 | 9 |
| Gross Profit | 15 | 9 | 18 | 16 | 15 |
| Operating Expenses | 394 | 411 | 460 | 538 | 386 |
| Operating Income | -374 | -397 | -435 | -515 | -363 |
| Interest Expense | 192 | 169 | 176 | 154 | 516 |
| Other Income | -1 | 0 | 40 | -487 | 238 |
| Pre-tax Income | -567 | -565 | -570 | -1,156 | -641 |
| Net Income Continuous | -567 | -565 | -570 | -1,156 | -641 |
| Net Income | $-567 | $-565 | $-570 | $-1,156 | $-641 |
| EBITDA(a) | $-182 | $-228 | $-260 | $-366 | $148 |